F. Al-Kandari

Electrophysiologic and Antiarrhythmic Effects of the New Class III Antiarrhythmic Drug KCB-328 in Experimental Canine Atrial Flutter

G. Feld, A. Gupta, M. Wadhwa, 2001, Journal of cardiovascular pharmacology and therapeutics.

Successful Implantation of Cardiac Defibrillators Without Induction of Ventricular Fibrillation Using Upper Limit of Vulnerability Testing

G. Feld, A. Garg, G. Ungab, 2003, Journal of Interventional Cardiac Electrophysiology.

Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real‐world global setting: Results from the Cryo AF Global Registry

K. Okumura, K. J. Chun, C. Földesi, 2021, Journal of arrhythmia.

Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry

K. Okumura, Y. On, R. Rordorf, 2021, Journal of the American Heart Association.

Successful Implantation of a Permanent Pacemaker through a Persistent Left Superior Vena cava

Ali Al-Sayegh, F. Al-Kandari, 2002, Medical Principles and Practice.

The Prevalence of Atrial Fibrillation among Acute Medical Admissions in Kuwait

Z. Bitar, M. Ridha, F. Redha, 2005, Medical Principles and Practice.

Healthcare utilization after cryoballoon ablation for treatment of atrial fibrillation in patients with heart failure: real-world results from the Cryo AF Global Registry

K. Chun, R. Rordorf, C. Földesi, 2021 .

Impact of first-line cryoablation for atrial fibrillation on healthcare utilization, arrhythmia disease burden and efficacy outcomes: real-world evidence from the Cryo Global Registry

K. Chun, Y. On, G. Zucchelli, 2022, Journal of Interventional Cardiac Electrophysiology.